Defense Award | SPE2DB22D1200 | PRIME VENDOR PHARM BRANCH-PHILADELPHIA

SPE2DB22D1200 - PRIME VENDOR PHARM BRANCH-PHILADELPHIA

Federal Contract Award Search » IDC Award

This IDC contract for Pharmaceuticals > Pharmaceutical Products was awarded in FY2022 on Mar 23, 2022 to Cencora by DLA Medical Directorate. There have been $34.7M in obligations to date with a ceiling value of $1,000M, showing a 3% burn rate so far on the contract. The contract was not competed under any preference program with 4 offers received. We expect a 3 year duration with ultimate completion date of Dec 30, 2025.

Cencora is a contractor located in PA, doing primarily Pharmaceuticals > Pharmaceutical Products work for Defense. The company receives $2.2B annually in federal awards (as of FY2020). Also, they have shown success winning IDC contracts concentrated mainly on a singular customer focused portfolio.

The Federal Government competes and awards an Indefinite Delivery Contract (IDC) to support requirements where the quantity and time of delivery are unknown. Typically referred to as Indefinite Delivery-Indefinite Quantity (IDIQ) contracts, the Government has the option of awarding a single or multiple award IDIQ. Once awarded, an IDIQ acts as a master agreement between the Federal Government and one or more contractors. On an as-needed basis, Federal buying organizations place orders, commonly referred to as Task Orders against an IDIQ, to purchase goods or services available through the IDIQ.

Read the full report


Contract Number
SPE2DB22D1200
Obligations to Date
$34.7M
Ceiling Value
$1,000M
Award Date
03/23/2022
Contract Type
IDC
Competition Set Aside Type
No set aside used

Buying Agency/Office
Defense»Defense Logistics Agency (DLA)»DLA Troop Support»DLA Medical Directorate


Win More Federal Business

Imagine a world where every report, every insight is tailored specifically to you. Our entire platform is configured around your past performance so that everything is relevant.

Collaboration Stack

All the Right Tools

Business Development & Pipeline Management

We start with the largest federal opportunity database, including forecasts and re-competes, and add layer a suite of pipeline management tools.

Personalized Markets

Our market-centric platform adds context to every pursuit. Every opportunity, every report, tailored specifically to you.

Award Research & Market Intelligence

Find gaps in the market, identify key competitors and teaming partners, evaluate performance, and analyze pathways to new business.

Start Your Free Account Today

Gain Full Access to This Report and...
Contract Opportunities
Pipeline Management
Award Research
Funding Analysis
Partner Identification
Industry and Market Intel
Agency Spending Trends
Competitive Insights

Federal Compass is software designed for today’s federal market.

Explore how the right intel and process can help lead your team to greater success.

Create Free Account

Enjoy instant access to the Federal Compass platform

Task Order History

Task Order No. Contractor Obligations Effective Date
SPE2DB22FM8QM AMERISOURCEBERGEN DRUG CORPORATION $5.2k 05/03/2022
SPE2DB22FM8QL AMERISOURCEBERGEN DRUG CORPORATION $95.46 05/03/2022
SPE2DB22FM8QD AMERISOURCEBERGEN DRUG CORPORATION $339.52 05/03/2022
SPE2DB22FM8QQ AMERISOURCEBERGEN DRUG CORPORATION $9.6k 05/03/2022
SPE2DB22FM8QK AMERISOURCEBERGEN DRUG CORPORATION $3.15 05/03/2022
SPE2DB22FM8QE AMERISOURCEBERGEN DRUG CORPORATION $96.80 05/03/2022
SPE2DB22FM8QF AMERISOURCEBERGEN DRUG CORPORATION $29.04 05/03/2022
SPE2DB22FM8QG AMERISOURCEBERGEN DRUG CORPORATION $14.8k 05/03/2022
SPE2DB22FM8QN AMERISOURCEBERGEN DRUG CORPORATION $20k 05/03/2022
SPE2DB22FM8QJ AMERISOURCEBERGEN DRUG CORPORATION $234.36 05/03/2022
SPE2DB22FM8QP AMERISOURCEBERGEN DRUG CORPORATION $324.00 05/03/2022
SPE2DB22FM8QH AMERISOURCEBERGEN DRUG CORPORATION $1.8k 05/03/2022
SPE2DB22FM8QR AMERISOURCEBERGEN DRUG CORPORATION $242.18 05/04/2022
SPE2DB22FM8RD AMERISOURCEBERGEN DRUG CORPORATION $3.2k 05/04/2022
SPE2DB22FM8QW AMERISOURCEBERGEN DRUG CORPORATION $37.4k 05/04/2022
SPE2DB22FM8QV AMERISOURCEBERGEN DRUG CORPORATION $1.4k 05/04/2022
SPE2DB22FM8QX AMERISOURCEBERGEN DRUG CORPORATION $324.12 05/04/2022
SPE2DB22FM8QY AMERISOURCEBERGEN DRUG CORPORATION $9.2k 05/04/2022
SPE2DB22FM8QU AMERISOURCEBERGEN DRUG CORPORATION $1.7k 05/04/2022
SPE2DB22FM8QZ AMERISOURCEBERGEN DRUG CORPORATION $1.9k 05/04/2022

Contracting Resources